Norfloxacin-induced rheumatic disease.
D000328:Adult; D000890:Anti-Infective Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009268:Nalidixic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D009643:Norfloxacin; D052256:Tendinopathy / Q000139:chemically induced*
D000890:Anti-Infective Agents; D009268:Nalidixic Acid; D009643:Norfloxacin